Judea Wiggins, MD

Robert Yoo, DO, is a medical oncologist and an assistant professor in the Department of Neurology at Barrow Neurological Institute. He is board certified in medical oncology and hematology by the American Osteopathic Board of Internal Medicine. Dr. Yoo’s expertise includes caring for patients with aggressive primary brain tumors, such as glioblastoma, and tumors that have metastasized to the brain or spine. With his hematology background, Dr. Yoo also treats blood cancer types involving the brain and spine, such as lymphoma or multiple myeloma. He is a member of the American Osteopathic Association, the American Society of Clinical Oncology, the American Society of Hematology, and the Society for Neuro-Oncology. Dr. Yoo earned his medical degree from the Michigan State University College of Osteopathic Medicine in East Lansing. He completed his internal medicine residency at Beaumont Hospital in Farmington Hills, the primary teaching hospital of Michigan State University. He also completed a fellowship in hematology and oncology at the Barbara Ann Karmanos Cancer Institute, an affiliate of the Wayne State University School of Medicine in Detroit. Dr. Yoo has a longstanding interest in genomics and tumors with unique molecular biology. He believes that a better understanding of tumor biology can help overcome treatment resistance to provide precision-based treatments for brain tumors. Dr. Yoo emphasizes comprehensive, state-of-the-art patient care with treatment options such as immunotherapy, targeted therapy agents, and cancer vaccines.

Barrow Oncology is a full-service, complete cancer care team that allows patients with benign and malignant tumors to have all of their oncological services provided and coordinated in the same center. We offer a multidisciplinary team of neurosurgeons, head and neck surgeons, medical oncologists, neuro-oncologists, speech-language pathologists, ENT specialists, and radiation oncologists offering the latest treatment for head and neck cancer, neurological cancers, and metastatic cancers.

Yoshie Umemura, MD, is the Division Chief of Neuro-Oncology, the William R. and Joan R. Shapiro Chair in Neuro-Oncology Research, associate professor of neurology at Barrow Neurological Institute, and Chief Medical Officer at the Ivy Brain Tumor Center. She is board certified in neurology by the American Board of Psychiatry and Neurology, as well as neuro-oncology by the United Council for Neurologic Subspecialties. Dr. Umemura’s expertise rests on the axis of brain tumors and cancers of the central nervous system, as well as the neurological complications from cancer. She is a member of the American Academy of Neurology, the American Society of Clinical Oncology, the International Primary CNS Lymphoma Collaborative Group, and the Society for Neuro-Oncology.